Important SCDM CCDM Exam Questions

Answer: B

Explanation:

The correct and compliant sequence for EDC system setup and implementation begins only after the study protocol is finalized, as all case report form (CRF) designs, database structures, and validation rules derive directly from the finalized protocol.

According to GCDMP (Chapter: EDC Systems Implementation), the proper order is:

Protocol finalized -- defines endpoints and data requirements.

Database created -- built according to the protocol and CRFs.

Edit checks created -- programmed to validate data entry accuracy.

Database tested (UAT) -- ensures functionality, integrity, and compliance.

Sites trained and system released -- only then can data entry begin.

Option B follows this logical and regulatory-compliant sequence. Other options (A, C, D) are either paper-based workflows or violate GCP-compliant timelines (e.g., enrolling subjects before database validation).

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Electronic Data Capture (EDC) Systems, Section 5.2 -- System Setup and Implementation Flow

ICH E6(R2) GCP, Section 5.5.3 -- Computerized Systems Validation and User Training Before Use

FDA 21 CFR Part 11 -- Validation and System Release Requirements

Answer: D

Explanation:

The most effective method for quality control (QC) of the query resolution process is to perform random audits of resolved query forms. This ensures that queries are being appropriately raised, addressed, and resolved in accordance with the study protocol, data management plan (DMP), and standard operating procedures (SOPs).

According to the GCDMP (Chapter: Data Validation and Cleaning), QC activities should verify that the data review and query management process maintains high accuracy and consistency. Random auditing of resolved queries enables verification that:

Queries were raised for legitimate discrepancies,

The site's responses were appropriate, and

The resolution actions taken by data management were correct and well-documented.

Metrics such as turnaround time (options A and C) or query counts (option B) measure efficiency but do not assess quality. True quality control focuses on ensuring that data corrections preserve accuracy, auditability, and traceability --- the fundamental principles of data integrity in clinical research.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 5.4 -- Query Management and Quality Control

ICH E6 (R2) GCP, Section 5.5.3 -- Data Integrity and Validation Procedures

Answer: D

Explanation:

Regulatory agencies such as the FDA and ICH require that electronic data be retained in a format that preserves audit trails and traceability.

While PDF images (option C) provide a static representation of data, they do not preserve the underlying audit trail (i.e., who changed what, when, and why). The ASCII data files with corresponding audit trails (option D) provide complete transparency and comply with 21 CFR Part 11 and GCDMP archival standards.

Option A (storing computers) is unnecessary and impractical, and Option B (paper source documents) are site records, not system archives.

Hence, option D is correct --- ASCII data files with audit trails meet traceability and compliance standards.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Database Lock and Archiving, Section 5.4 -- Archival Formats and Audit Trail Retention

ICH E6(R2) GCP, Section 5.5.3 -- Data Integrity, Audit Trails, and Record Retention

FDA 21 CFR Part 11 -- Electronic Records; Audit Trail and Retention Requirements

Answer: D

Explanation:

RACI is a project management and governance framework used to define roles and responsibilities within a project. Each letter represents a distinct role type:

Responsible (R): The person(s) who perform the work or execute the task.

Accountable (A): The individual ultimately answerable for the task's completion and success (only one per activity).

Consulted (C): Subject matter experts who provide input or guidance before decisions are made.

Informed (I): Individuals kept up to date on progress or outcomes but not directly involved in execution.

The RACI model ensures clarity in ownership and accountability, preventing duplication of effort or responsibility confusion. It is a key component of the GCDMP (Chapter: Project Management in Data Management) for ensuring clear delegation and communication within clinical data management teams.

Hence, option D is correct.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Project Management in Data Management, Section 5.1 -- Roles, Responsibilities, and RACI Matrices

Project Management Institute (PMI) Framework -- Responsibility Assignment Matrices (RACI)

ICH E6(R2) GCP, Section 5.1.1 -- Defined Roles and Quality Oversight Responsibilities

Answer: D

Explanation:

In this scenario, the site has deviated from the approved study protocol by using a different formulation (nebulized albuterol instead of inhaler). This is considered a protocol deviation or violation, depending on study definitions.

Per GCDMP (Chapter: Data Validation and Cleaning) and ICH E6(R2), Data Managers are responsible for ensuring that all protocol deviations affecting data integrity or subject safety are accurately captured and documented within the clinical database. The appropriate action is to issue a data query prompting the site to record the deviation in the designated section (e.g., ''Protocol Deviations'' CRF).

Option A: Incorrect --- it affects data comparability.

Option B: Escalation to the Ethics Committee is handled by the sponsor, not the Data Manager.

Option C: Updating the CRF guidelines is premature; first, the deviation must be logged and assessed.

Therefore, option D (Query the site to enter a Protocol Violation) is the correct and compliant action.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 6.2 -- Query Management and Protocol Deviations

ICH E6(R2) GCP, Section 4.5 -- Compliance with Protocol

FDA Guidance for Industry: Oversight of Clinical Investigations --- Compliance and Protocol Deviation Reporting